Searched for
TUBERCULOSIS PROGRAMS IN INDIA
Study highlights 'catastrophic costs' incurred by tuberculosis patients worldwideDespite many countries offering free treatment, tuberculosis patients still face significant costs. Hospitalisation and income loss are maj...- Trump's plan to 'suspend' US funding likely to hit health programmes hereUS President Donald Trump's executive order to suspend USAID programs may impact health initiatives in India, specifically targeting TB, HI...
- India has seen reduction in TB incidence: MandaviyaIndia has achieved a 13% reduction in TB incidence and a 15% reduction in mortality rate from 2015 to 2022, surpassing global reduction rat...
- World Vaccination Day: How to register your newborn for free government vaccinesAs the world celebrates World Vaccination Day, India's Universal Immunization Programme (UIP) continues to play a vital role in protecting ...
- Dr Subhash Babu, first Indian scientist to be awarded Bailey K. Ashford MedalThe American Society of Tropical Medicine and Hygiene (ASTMH) is the world's largest scientific organization in tropical medicine, and the ...
- TB patients at increased risk of all-cause mortality even after treatment: ICMRThough there is improved treatment outcome and a steady decline in mortality in recent years, long-term survival of these patients post tre...
- Pandemic has underlined importance of a quality healthcare system for all: President KovindIn his message on the eve of World Tuberculosis Day, which is observed every year on March 24, Kovind said that the entire National TB Elim...
- India is sitting on a healthcare time bomb, and no, it is not the coronavirusMore than a million children have missed crucial immunizations and hospital births have shown a sharp decline, indicating many women may ha...
- Mylan gets DCGI nod for anti-tuberculosis drug Pretomanid for conditional accessThe Drug Controller General of India (DCGI) has approved Pretomanid for conditional access under the National Tuberculosis Elimination Prog...
- US exit may hit WHO’s India workThe US is the largest donor to the WHO with a contribution of $400 million in 2018-19. WHO India’s country budget was reported to be a litt...
- J&J, Macleods in talks for licence deal of tuberculosis drugThe talks, which are in early stage, will allow Macleods to manufacture generic version of the drug, a move if goes through will improve ac...
- Otsuka enters deal with Mylan to bring MDR TB drug to IndiaThe Drug Controller General of India has granted Mylan’s subsidiary approval for the drug, according to a release by the company. The drug,...
- SAARC panel decides to dissolve 3 regional centresThe SAARC committee today decided to dissolve three regional centres, including one in India, and merge four others to end the duplication ...
- India inks USD 100 mn agreement with World Bank for treatment of TB"The project will contribute to scaling up free-of-charge MDR TB services, helping many more families avoid death and impoverishment.
- Cadila Pharmaceuticals ties up with NovaSAID for drug developmentNovaSAID AB and Ahmedabad-based drug maker Cadila have entered into a strategic partnership to develop new treatments for inflammation and ...
- Aadhaar to help eradicate poverty, says World Bank chief Jim Yong KimHighly impressed by Aaadhaar, Kim said this could help achieve the target of eradicating poverty by 2030 in ways big and small.
- Government to provide free tuberculosis drugs at all chemist shops and corporate hospitalsA patient, confirmed positive for TB by a qualified doctor, simply needs to register with the Revised National Tuberculosis Control Program.
- GVK BIO selected as preferred provider for 14 global PDPsDrug discovery research and development organisation GVK Biosciences has been selected as a preferred provider to a consortium of 14 global...
- Johnson & Johnson giving $200 million for health of women, kidsHealth giant Johnson & Johnson is donating about $200 million in cash and medicine to a sweeping United Nations program created to improve ...
- Ranbaxy transfers R&D unit to Daiichi SankyoRanbaxy Laboratories has transferred its research division for new drugs to Japan’s Daiichi Sankyo turning Ranbaxy into a pure generic drug...
Load More
